In two different studies, the decreased ability to identify odors was associated with the loss of brain cell function and progression to Alzheimer’s disease.
“We’re trying to be able to diagnose Alzheimer’s earlier and theoretically deliver drugs to people sooner,” said Matthew Growdon, lead author of one of the studies. “Think about cardiovascular disease as a paradigm; the idea is that we would find a way to control the risk factors [before the disease advances].”
The ability to smell is associated with the first cranial nerve, and is often one of the first things to be affected by cognitive decline.
Brain regions that process odors are particularly vulnerable to Alzheimer’s early in the disease process, explained Growdon, who is a student at Harvard Medical School, in Boston. Autopsies have shown amyloid plaques and neurofibrillary tangles — the telltale signs of Alzheimer’s — in the areas of the brain responsible for smell.
In a subgroup of study participants who had elevated levels of amyloid in their brain, there was evidence of greater brain cell death and diminished ability to smell, Growdon said. The data took into account the participants’ age, gender, intelligence and brain scans.
Alzheimer’s is the most common form of dementia, a general term for loss of memory and other intellectual abilities serious enough to interfere with daily life. Alzheimer’s disease accounts for 60 percent to 80 percent of dementia cases, according to the Alzheimer’s Association.
The research is to be presented Sunday at the Alzheimer’s Association International Conference in Copenhagen, Denmark. Findings presented at medical meetings are considered preliminary until they are published in a peer-reviewed journal.
For Growdon’s study, the researchers tapped 215 people from the Boston area who were between the ages of 64 and 88 and were participating in a research project designed to see whether results of brain scans are related to memory changes that occur in healthy older adults.